571 related articles for article (PubMed ID: 29426004)
21. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
22. Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics.
Yadollahpour A
Curr Top Med Chem; 2020; 20(27):2425-2426. PubMed ID: 33210582
[No Abstract] [Full Text] [Related]
23. Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead.
Akhter MH; Beg S; Tarique M; Malik A; Afaq S; Choudhry H; Hosawi S
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129777. PubMed ID: 33130062
[TBL] [Abstract][Full Text] [Related]
24. Actively targeted nanocarriers for drug delivery to cancer cells.
Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
[TBL] [Abstract][Full Text] [Related]
25. Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications.
Patitsa M; Karathanou K; Kanaki Z; Tzioga L; Pippa N; Demetzos C; Verganelakis DA; Cournia Z; Klinakis A
Sci Rep; 2017 Apr; 7(1):775. PubMed ID: 28396592
[TBL] [Abstract][Full Text] [Related]
26. Tumor Targeted Nanocarriers for Immunotherapy.
Baeza A
Molecules; 2020 Mar; 25(7):. PubMed ID: 32225049
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
28. Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery.
Yurkin ST; Wang Z
Nanomedicine (Lond); 2017 Aug; 12(16):2007-2019. PubMed ID: 28745122
[TBL] [Abstract][Full Text] [Related]
29. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
30. Polyester micelles for drug delivery and cancer theranostics: Current achievements, progresses and future perspectives.
Yi Y; Lin G; Chen S; Liu J; Zhang H; Mi P
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():218-232. PubMed ID: 29208282
[TBL] [Abstract][Full Text] [Related]
31. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
32. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
33. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
34. Chondroitin sulfate derived theranostic and therapeutic nanocarriers for tumor-targeted drug delivery.
Khan AR; Yang X; Du X; Yang H; Liu Y; Khan AQ; Zhai G
Carbohydr Polym; 2020 Apr; 233():115837. PubMed ID: 32059890
[TBL] [Abstract][Full Text] [Related]
35. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
36. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
38. Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold‑iron oxide nanocomposites: A pH-sensitive targeted drug delivery system for brain cancer theranostics.
Ghorbani M; Bigdeli B; Jalili-Baleh L; Baharifar H; Akrami M; Dehghani S; Goliaei B; Amani A; Lotfabadi A; Rashedi H; Haririan I; Alam NR; Hamedani MP; Khoobi M
Eur J Pharm Sci; 2018 Mar; 114():175-188. PubMed ID: 29248558
[TBL] [Abstract][Full Text] [Related]
39. Membrane-encapsulated camouflaged nanomedicines in drug delivery.
Ghosh S; Girigoswami K; Girigoswami A
Nanomedicine (Lond); 2019 Aug; 14(15):2067-2082. PubMed ID: 31355709
[TBL] [Abstract][Full Text] [Related]
40. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]